Title:
微細化医薬組成物
Document Type and Number:
Japanese Patent JP6461902
Kind Code:
B2
Abstract:
Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometers but not less than 3 micrometers and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.
Inventors:
Flynn Richard Anthony
Slana Raffle
Chetley Anil
Farrington David
Saint-Villithesh
Slana Raffle
Chetley Anil
Farrington David
Saint-Villithesh
Application Number:
JP2016500810A
Publication Date:
January 30, 2019
Filing Date:
March 07, 2014
Export Citation:
Assignee:
Forest Laboratories Holdings Limited
Flynn Richard Anthony
Slana Raffle
Chetley Anil
Farrington David
Saint-Villithesh
Flynn Richard Anthony
Slana Raffle
Chetley Anil
Farrington David
Saint-Villithesh
International Classes:
A61K38/08; A61K38/12; A61K9/14; A61K9/64; A61K9/72; A61P31/04
Domestic Patent References:
JP2002526435A |
Attorney, Agent or Firm:
Patent Business Corporation Minori Patent Office